biote Corp.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $192.2M | $197.2M | $185.4M | $165.0M | $139.4M |
| Selling, general & administrative | $101.8M | $107.5M | $98.8M | $171.1M | $49.1M |
| Operating income | $35.6M | $31.6M | $28.7M | -$60.7M | $34.6M |
| Pretax income | $37.6M | $1.0M | -$123,000 | $1.7M | $32.9M |
| Income tax expense | $6.0M | $970,000 | $2.7M | $388,000 | $286,000 |
| Net income | $27.0M | $3.2M | $3.3M | -$969,000 | $11.1M |
| Balance Sheet | |||||
| Cash and equivalents | $24.1M | $39.3M | $89.0M | $79.2M | $130,359 |
| Current assets | $54.7M | $68.1M | $122.3M | $101.2M | $47.1M |
| Total assets | $107.6M | $122.4M | $155.3M | $111.6M | $54.3M |
| Current liabilities | $45.0M | $51.5M | $22.2M | $18.8M | $17.3M |
| Total liabilities | $158.0M | $224.6M | $191.8M | $169.9M | $50.2M |
| Total debt | $103.1M | $109.4M | $115.6M | $121.9M | $37.5M |
| Stockholders' equity | -$58.5M | -$105.9M | -$29.4M | -$44.5M | $4.1M |
| Cash Flow Statement | |||||
| Cash from operations | $35.2M | $45.2M | $26.9M | -$9.2M | $33.7M |
| Depreciation and amortization | $3.7M | $3.6M | $3.0M | $2.2M | $1.4M |
| Stock-based compensation | $8.9M | $8.7M | $9.1M | $82.2M | — |
| Capital expenditure | $5.0M | $6.4M | $359,000 | $333,000 | $1.4M |
| Free cash flow | $30.2M | $38.8M | $26.5M | -$9.5M | $32.3M |
| Dividends paid | $1.7M | $4.7M | $8.7M | $12.9M | $11.4M |
| Share repurchases | $3.4M | $5.6M | — | — | — |
| Impairments | $0 | $0 | $0 | $0 | $0 |
Shares outstanding 37.6M · Free float 56.4%
Annual filing data through FY ended December 31, 2025; float as of July 16, 2026.